1. Dose‐escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF‐mutated advanced cancers. Issue 3 (29th October 2020) Authors: Janku, Filip; Sakamuri, Divya; Kato, Shumei; Huang, Helen J.; Call, S. Greg; Naing, Aung; Holley, Veronica R.; Patel, Sapna P.; Amaria, Rodabe N.; Falchook, Gerald S.; Piha‐Paul, Sarina A.; Zinner, Ralph G.; Tsimberidou, Apostolia M.; Hong, David S.; Meric‐Bernstam, Funda Journal: Cancer Issue: Volume 127:Issue 3(2021) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗